Search

everythinglearnresearchcommunity

for

Search:↓

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Lower zinc levels may predict less effective hair loss treatment.

Sublingual minoxidil safely promotes hair growth.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Esthetic surgery complications can include infections, nerve injury, and more; proper evaluation and technique help prevent them.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Early intervention and patient education are crucial for managing alopecia areata.

Finasteride effectively treats hair loss in men with minimal side effects.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Certain genes may influence hair loss differently in men and women.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Peanut callus extract helps grow hair and prevent hair loss.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

New understanding and treatments for hair loss are improving, but more research is needed.